Trial · NCT00592475
Results by group183
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 183
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Baseline | 16.58 | Standard Deviation 4.375 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Baseline | 18.33 | Standard Deviation 4.750 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Baseline | 15.80 | Standard Deviation 6.601 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Change at 0.5 Hours | 0.33 | Standard Deviation 1.080 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Change at 0.5 Hours | 0.11 | Standard Deviation 1.318 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Change at 0.5 Hours | -0.10 | Standard Deviation 0.224 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Change at 1 Hour | 0.50 | Standard Deviation 1.844 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Change at 1 Hour | 0.56 | Standard Deviation 1.357 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Change at 1 Hour | -0.60 | Standard Deviation 0.418 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Change at 1.5 Hours | 0.83 | Standard Deviation 2.113 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Change at 1.5 Hours | 0.83 | Standard Deviation 1.732 | mmHg |
| Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Change at 1.5 Hours | -0.10 | Standard Deviation 1.294 | mmHg |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Baseline (N= 4; 9; 5) | 581.0 | Standard Deviation 77.49 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Baseline (N= 4; 9; 5) | 1182.2 | Standard Deviation 530.56 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Baseline (N= 4; 9; 5) | 649.6 | Standard Deviation 300.44 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Change at 0.5 Hours (N= 4; 9; 5) | 53.5 | Standard Deviation 161.30 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Change at 0.5 Hours (N= 4; 9; 5) | -74.1 | Standard Deviation 558.58 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 3 Placebo | Change at 0.5 Hours (N= 4; 9; 5) | 73.8 | Standard Deviation 196.75 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 1 Conivaptan 12.5 mg | Change at 1 Hour (N= 4; 9; 4) | 1.3 | Standard Deviation 160.23 | mL/min |
| Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose | Regimen 2 Conivaptan 25 mg | Change at 1 Hour (N= 4; 9; 4) | -70.0 | Standard Deviation 318.35 | mL/min |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00592475/results